Patents by Inventor Christopher Benjamin Phelps

Christopher Benjamin Phelps has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Method of treatment comprising administration of a cytokine antagonist molecule
    Patent number: 7803383
    Abstract: This invention relates to novel uses of a protein sequence (INSP052EC), herein identified as an immunoglobulin domain-containing cell surface recognition, in the diagnosis, prevention and treatment of diseases, in particular those related to the excessive expression and/or secretion of cytokines.
    Type: Grant
    Filed: November 12, 2004
    Date of Patent: September 28, 2010
    Assignee: Ares Trading S.A.
    Inventors: Richard Joseph Fagan, Andrew Robert Davids, Christopher Benjamin Phelps, Christine Power, Ursula Boschert, Yolande Chvatchko
  • Cystine-Knot Fold Cytokine
    Publication number: 20100048467
    Abstract: This invention relates to a novel protein (INSP002), herein identified as a secreted protein that is a member of the Dan family of the cystine-knot fold cytokine superfamily and to the use of this protein and nucleic acid sequences from the encoding genes in the diagnosis, prevention and treatment of disease.
    Type: Application
    Filed: January 12, 2006
    Publication date: February 25, 2010
    Applicant: ARES TRADING S.A.
    Inventors: Mark Douglas Davies, Christopher Benjamin Phelps, Richard Joseph Fagan, Christine Power, Melanie Yorke, Mark Ibberson, Yan Lavrovsky
  • Cytokine antagonist molecules
    Patent number: 7622555
    Abstract: This invention relates to a novel protein (INSP052), herein identified as an immunoglobulin domain-containing cell surface recognition molecule and to the use of this proteins and nucleic acid sequences from the encoding gene in the diagnosis, prevention and treatment of disease. The invention also relates to the identification of the extracellular domain of INSP052.
    Type: Grant
    Filed: November 12, 2003
    Date of Patent: November 24, 2009
    Assignee: Ares Trading S.A.
    Inventors: Andrew Robert Davids, Richard Joseph Fagan, Christopher Benjamin Phelps, Christine Power, Yolande Chvatchko, Ursula Boschert
  • Cystine-knot fold protein
    Patent number: 7619065
    Abstract: This invention relates to a novel protein (INSP002), herein identified as a secreted protein that is a member of the Dan family of the cystine-knot fold cytokine superfamily and to the use of this protein and nucleic acid sequences from the encoding genes in the diagnosis, prevention and treatment of disease.
    Type: Grant
    Filed: June 21, 2004
    Date of Patent: November 17, 2009
    Assignee: Ares Trading S.A.
    Inventors: Mark Douglas Davies, Christopher Benjamin Phelps, Richard Joseph Fagan, Christine Power, Melanie Yorke, Mark Ibberson
  • Splice variant of human placental growth hormone
    Patent number: 7605129
    Abstract: This invention relates to a protein, termed INSP105, herein identified as a splice variant of human placental growth hormone and to the use of this protein and nucleic acid sequences from the encoding genes in the diagnosis, prevention and treatment of disease.
    Type: Grant
    Filed: December 19, 2003
    Date of Patent: October 20, 2009
    Inventors: Richard Joseph Fagan, Christopher Benjamin Phelps, Tania Maria Rodrigues, Christine Power, Mariastella De Tiani
  • Metalloprotease proteins
    Patent number: 7557079
    Abstract: This invention relates to proteins termed INSP005a and INSP005b, herein identified as secreted proteins, in particular members of the metalloprotease family and to the use of these proteins and nucleic acid sequences from the encoding genes in the diagnosis, prevention, and treatment of disease.
    Type: Grant
    Filed: December 23, 2003
    Date of Patent: July 7, 2009
    Assignee: Ares Trading, S.A.
    Inventors: Richard Joseph Fagan, Christopher Benjamin Phelps, Christine Power, Richard James Mitter, Ursula Boschert, Yolande Chvatchko
  • Splice variant of the human pituitary growth hormone
    Patent number: 7531508
    Abstract: This invention relates to a novel protein, termed INSP101, herein identified as a novel splice variant of human pituitary growth hormone and to the use of this protein and nucleic acid sequences from the encoding genes in the diagnosis, prevention, and treatment of disease.
    Type: Grant
    Filed: December 5, 2003
    Date of Patent: May 12, 2009
    Assignee: Ares Trading S.A.
    Inventors: Richard Joseph Fagan, Christopher Benjamin Phelps, Tania Maria Rodrigues, Melanie Yorke, Mariastella De Tiani
  • TNF-like secreted protein
    Patent number: 7514533
    Abstract: This invention relates to novel protein INSP058, herein identified as TNF-like secreted protein, and to the use of this protein and the nucleic acid sequence from the encoding gene in the diagnosis, prevention, and treatment of disease.
    Type: Grant
    Filed: May 21, 2003
    Date of Patent: April 7, 2009
    Assignee: Ares Trading S.A.
    Inventors: Stephen Noel Fitzgerald, Richard Joseph Fagan, Christopher Benjamin Phelps, Christine Power, Mark Ibberson, Melanie Yorke
  • IL-8 Like Protein
    Publication number: 20080199435
    Abstract: This present invention relates to a novel protein, termed INSP085, herein identified as an IL-8 like protein and to the use of this protein and nucleic acid sequence from the encoding genes in the diagnosis, prevention and treatment of disease.
    Type: Application
    Filed: March 11, 2008
    Publication date: August 21, 2008
    Inventors: Richard Fagan, Christopher Benjamin Phelps, Mark Douglas Davies, Christine Power
  • IL-8 like protein
    Patent number: 7341851
    Abstract: This present invention relates to a novel protein, termed INSP085, herein identified as an IL-8 like protein and to the use of this protein and nucleic acid sequence from the encoding genes in the diagnosis, prevention and treatment of disease.
    Type: Grant
    Filed: February 18, 2005
    Date of Patent: March 11, 2008
    Assignee: Ares Trading, S.A.
    Inventors: Richard Fagan, Christopher Benjamin Phelps, Mark Douglas Davies, Christine Power
  • Cytokine Antagonist Molecules
    Publication number: 20080025951
    Abstract: This invention relates to novel uses of a protein sequence (INSP052EC), herein identified as an immunoglobulin domain-containing cell surface recognition, in the diagnosis, prevention and treatment of diseases, in particular those related to the excessive expression and/or secretion of cytokines.
    Type: Application
    Filed: November 12, 2004
    Publication date: January 31, 2008
    Applicant: ARES TRADING S.A.
    Inventors: Richard Joseph Fagan, Andrew Robert Davids, Christopher Benjamin Phelps, Christine Power, Ursula Boschert, Yolande Chvatchko
  • Nuclear hormone receptor ligand binding domain
    Publication number: 20040249123
    Abstract: This invention relates to a novel protein, termed BAA22563.1, herein identified as a Nuclear Hormone Receptor Ligand Binding Domain and to the use of this protein and nucleic acid sequence from the encoding gene in the diagnosis, prevention and treatment of disease.
    Type: Application
    Filed: April 9, 2004
    Publication date: December 9, 2004
    Inventors: Richard Joseph Fagan, Christopher Benjamin Phelps, Tom Phillips, Valerie Nathalie Pierron, Kathryn Elizabeth Allen, Janet Marjorie Allen, Sarah Jane Neill
  • Nuclear hormone receptor ligand binding domain
    Publication number: 20040249132
    Abstract: This invention relates to a novel protein, termed LBDG3, herein identified as a Nuclear Hormone Receptor Ligand Binding Domain and to the use of this protein and nucleic acid sequence from the encoding genes in the diagnosis, prevention and treatment of disease.
    Type: Application
    Filed: June 14, 2004
    Publication date: December 9, 2004
    Inventors: Richard Joseph Fagan, Christopher Benjamin Phelps, Valerie Nathalie Pierron, Kathryn Elizabeth Allen, Sarah Jane Neill
  • Cytokine antagonist molecules
    Publication number: 20040204352
    Abstract: This invention relates to a novel protein (INSP052), herein identified as an immunoglobulin domain-containing cell surface recognition molecule and to the use of this proteins and nucleic acid sequences from the encoding gene in the diagnosis, prevention and treatment of disease. The invention also relates to the identification of the extracellular domain of INSP052.
    Type: Application
    Filed: November 12, 2003
    Publication date: October 14, 2004
    Inventors: Andrew Robert Davids, Richard Joseph Fagan, Christopher Benjamin Phelps, Christine Power, Yolande Chvatchko, Ursula Boschert
  • Nuclear hormone receptor ligand binding domain
    Publication number: 20040171804
    Abstract: This invention relates to a novel protein, termed BAA74848.1, herein identified as a Nuclear Hormone Receptor Ligand Binding Domain and to the use of this protein and nucleic acid sequence from the encoding gene in the diagnosis, prevention and treatment of disease.
    Type: Application
    Filed: March 25, 2004
    Publication date: September 2, 2004
    Inventors: Richard Joseph Fagan, Christopher Benjamin Phelps
  • Nuclear hormone receptor ligand binding domain
    Publication number: 20040170999
    Abstract: This invention relates to novel proteins, termed BAA31618.1, herein identified as a Nuclear Hormone Receptor Ligand Binding Domain and to the use of this proteins and nucleic acid sequence from the encoding genes in the diagnosis, prevention and treatment of disease.
    Type: Application
    Filed: April 13, 2004
    Publication date: September 2, 2004
    Inventors: Richard Joseph Fagan, Christopher Benjamin Phelps
  • Nuclear hormone receptor ligand binding domain
    Publication number: 20040147724
    Abstract: The invention relates to a novel protein, termed BAA07892.2, herein identified as a Nuclear Hormone Receptor Ligand Binding Domain and to the use of this protein and nucleic acid sequence from the encoding gene in the diagnosis, prevention and treatment of disease.
    Type: Application
    Filed: February 4, 2004
    Publication date: July 29, 2004
    Inventors: Richard Joseph Fagan, Christopher Benjamin Phelps
  • Nuclear hormone receptor ligand binding domain
    Publication number: 20040132038
    Abstract: This invention relates to novel proteins, termed BAA91543.1, herein identified as a Nuclear Hormone Receptor Ligand Binding Domain and to the use of this protein and nucleic acid sequence from the encoding gene in the diagnosis, prevention and treatment of disease.
    Type: Application
    Filed: February 6, 2004
    Publication date: July 8, 2004
    Inventors: Richard Joseph Fagan, Christopher Benjamin Phelps
  • Adhesion molecules
    Publication number: 20040132974
    Abstract: This invention relates to novel proteins, termed AAC74854.1, AAC76768.1 and P10155, herein identified as adhesion molecules and to the use of these proteins and nucleic acid sequences from the encoding genes in the diagnosis, prevention and treatment of disease.
    Type: Application
    Filed: July 8, 2003
    Publication date: July 8, 2004
    Inventors: Alex Gutteridge, Richard Joseph Fagan, Christopher Benjamin Phelps
  • Interferon gamma-like protein
    Publication number: 20040106778
    Abstract: This application discloses and claims a protein, herein identified as an interferon gamma-like secreted protein of the of the four helical bundle cytokine fold, and to the use of this protein and nucleic acid sequences from the encoding gene in the diagnosis, prevention and treatment of disease.
    Type: Application
    Filed: June 20, 2003
    Publication date: June 3, 2004
    Inventors: Richard Joseph Fagan, Christopher Benjamin Phelps, Alex Gutteridge, Christine Power, Ursula Boschert, Yolande Chvatchko